US EditionThe Medicine Crisis In Iran: Over 83% Of The Pharmaceutical Market Is Controlled By Quasi-Governmental Entities
Summary by Iran Focus
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The Medicine Crisis In Iran: Over 83% Of The Pharmaceutical Market Is Controlled By Quasi-Governmental Entities
While Iran’s regime claims to intervene in the healthcare economy to support vulnerable groups, a report by the regime’s Majlis (Parliament) Research Center and official statistics show that patients’ share of treatment costs in Iran has risen to as much as 70%, and more than 83% of the pharmaceutical sales market is controlled by 55 quasi-governmental companies. On Monday, June 9, the state-run daily Shargh, citing a report by the regime’s Majl…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
